Patented Medicine Prices Review Board Will Hear Evidence in the Matter of the Price of Orphan Drug Soliris
OTTAWA, ONTARIO--(Marketwired - Jan 11, 2017) - Patented Medicine Prices Review Board The Patented Medicine Prices Review Board (the Board) will hold a public hearing in the matter of the price of the patented medicine Soliris and Alexion Pharmaceuticals …